BioCentury
ARTICLE | Company News

Nanogen, Institute Pasteur deal

November 3, 2003 8:00 AM UTC

Institute Pasteur granted NGEN exclusive European rights to IP covering the detection of mutations in the GJB2 gene to diagnose hereditary deafness. Nanogen plans to develop a molecular diagnostic pr...